Skip to main content

Good evening, here are the coronavirus updates you need to know tonight.

Top headlines:

  1. There hasn’t been any evidence to connect blood clots with the Oxford-AstraZeneca vaccine, the European Medicines Agency says
  2. A national advisory panel says AstraZeneca’s COVID-19 vaccine is safe and effective for seniors – reversing an earlier decision
  3. The staffing crisis in Ontario’s seniors homes is worsening, according to a source

In the last 7 days, 22,352 cases were reported, up 8 per cent from the previous 7 days. There were 215 deaths announced, down 17 per cent over the same period. At least 2,035 people are being treated in hospitals and 861,824 others are considered recovered.

About 80 per cent of the 4,104,060 doses of vaccine distributed to provinces have been administered. Canada’s inoculation rate is 36th among 84 countries with a population of one million or more people.

Open this photo in gallery:

Sources: Canada data is compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopeningVaccine distribution planFour vaccines approved in CanadaEssential resources


Photo of the day

Open this photo in gallery:

Dona Dainda, 75, celebrates after getting her first shot of the Sinovac vaccine for COVID-19 inside her home in the Kalunga Vao de Almas quilombo on the outskirts of Cavalcante, Goias state, Brazil, Tuesday, March 16, 2021. The local government's coronavirus vaccination campaign is reaching some quilombos, which are communities of people descended from runaway slaves.Eraldo Peres/The Associated Press


Coronavirus in Canada


In Ottawa, the national immunization advisory panel says there is now sufficient “real-world evidence” to show AstraZeneca’s vaccine is safe for seniors – reversing a recommendation made two weeks ago.

  • Previously, the panel said AstraZeneca didn’t have enough people over 65 in its trial. Two additional studies of patients published since the March 1 recommendation have been released and show that the vaccine “is both safe and effective for seniors,” the panel said.
  • The panel also said that because data shows shots from Pfizer and Moderna are more effective, those vaccines should be prioritized for seniors and other high-risk populations.
  • Provincial governments will now have to decide if they revise how they use the AstraZeneca vaccine.

COVID-19 vaccines: Moderna has started a study to test its vaccine on children and babies. The trial is expected to enroll 6,750 healthy children in the United States and Canada.


Coronavirus around the world


Coronavirus and business

One chart posted to Twitter by BMO economist Robert Kavcic illustrates the sheer absurdity of the recent jump in home prices amid the pandemic.

  • “If it’s not fully apparent to all parties that the Canadian housing market is boiling, this picture might convey the message,” the senior economist tweeted.

Also today: The number of gig workers is rapidly growing in Canada to counteract layoffs and rising costs of living due to COVID-19. But this tax season, many are struggling to understand tax filing obligations.

Rob Carrick: A year into the pandemic, the biggest threats to your finances are in the housing market, the stock market and the supermarket.


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe